Magnitude Biosciences

Magnitude Biosciences is a specialist Contract Research Organisation (CRO) that provides customized C. elegans studies to both industry and academic clients. The company operates in the biotechnology and pharmaceutical research markets, leveraging its expertise in C. elegans and unique automated imaging technology to generate high-quality, reproducible data. This data helps clients accelerate their research projects, particularly in drug development and ageing research. Founded in 2018 by leading experts in C. elegans and automated imaging, Magnitude Biosciences aims to bring the benefits of this unique research approach to the industry, thereby contributing to the development of new drug therapies and other research advances that improve human and environmental health. The business model is service-based, earning revenue through contract research services tailored to the specific needs of each client.

Keywords: C. elegans, automated imaging, drug development, ageing research, biotechnology, pharmaceutical, reproducible data, contract research, CRO, customized studies.